Abstract
Curcumin is the yellow pigment of Curcuma longa that irreversibly inhibits the activity of thioredoxin reductase (TrxR) and forms adduct. TrxR, a homodimeric enzyme with E and F chains, is responsible for redox control of the cell and defense against oxidative stress. It is also well known that TrxR is over-expressed in tumor cells. Hence TrxR is a promising target for curcumin based therapy. Binding site of TrxR for curcumin is at the interface of homodimers. In the present study, naturally occurring curcuminoids and forty four synthetic analogs of curcumin were docked with SP/XP glide suite and E-pharmacophore was simulated. E-pharmacophore of both chains has shown three donor features and one acceptor feature. 3D atom based QSAR models have been proposed for the two series of curcumin analogues of known IC50values. The data obtained indicates that the training set model is quite efficient to predict the test set of data. Obtained models and ADMET prediction could be employed for design and synthesis of more potent inhibitors of TrxR.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Interdisciplinary Sciences: Computational Life Sciences
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
